Biotechnology Value Fund holds 5.6%
Filed 09/30
Health care sectorNasdaq
13F filers: 198 · 0 since the quarter before · 06/30 holdings
Famous funds that held Stoke Therapeutics in their latest 13F report.
| Fund | Value | Since the quarter before |
|---|---|---|
| Mirae Asset Global ETFS HoldingsStoke Therapeutics STOK · 06/30 holdings | $2.6M | No quarter before |
| Mirae Asset Global InvestmentsStoke Therapeutics STOK · 06/30 holdings | $91.1K | Trimmed −6.5% |
| Holder | ||
|---|---|---|
| Biotechnology Value Fund09/30 | 5.6%3,608,968 sh | First report |
| Lynx1 Capital Management08/14 | 6.5%4,038,404 sh | −1.6pp |
| Toronto Dominion Bank08/12 | 4.9%3,173,258 sh | −0.5pp |
| FMR08/06 | 8.5%5,313,100 sh | −1.3pp |
| Lynx1 Capital Management05/18 | 8.1%4,763,673 sh | +1.1pp |
| Redmile Group05/15 | 6.7%4,164,120 sh | −1.3pp |
| Wellington Management Group05/15 | 5.2%3,095,700 sh | First report |
| FMR02/05 | 9.8%5,600,920 sh | −2.7pp |
| Cowen Financial Products25/11/14 | 0%0 sh | −5.8pp |
| Toronto Dominion Bank25/11/14 | 5.8%3,173,258 sh | First report |
| FMR25/11/05 | 12.5%6,865,057 sh | −1.1pp |
| BlackRock25/10/17 | 6.8%3,732,540 sh | +1.0pp |
| Skorpios Trust25/08/26 | 4.1%2,256,181 sh | −1.9pp |
| FMR25/08/06 | 13.6%7,412,982 sh | +2.9pp |
| BlackRock Portfolio Management25/07/15 | 4.7%2,550,341 sh | −0.4pp |
| Skorpios Trust25/06/23 | 6%3,256,181 sh | −1.2pp |
| Skorpios Trust25/06/06 | 7.2%3,906,181 sh | −5.8pp |
| FMR25/06/06 | 10.7%5,859,011 sh | First report |
| BlackRock Portfolio Management25/04/15 | 5.1%2,743,502 sh | First report |
| Skorpios Trust24/12/27 | 13%6,906,181 sh | No earlier report |